Evolve Clinical Research

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that attacks the peripheral nerves.

When the immune system damages the nerve’s protective coating (myelin), signals slow down — leading to weakness, numbness, and difficulty walking.

⸻

✨ Common Signs:
• Progressive weakness in arms & legs
• Tingling or numbness
• Balance issues
• Fatigue
• Reduced reflexes

🕒 Symptoms worsen over 8+ weeks (this helps distinguish it from more acute conditions).

⸻

💉 The good news? CIDP is treatable.
With IVIG, steroids, plasma exchange, and other therapies, many patients improve — especially with early diagnosis.

⸻

💜 CIDP is rare, but awareness matters.
Earlier recognition = faster diagnosis = better outcomes.

If you or someone you know has progressive weakness or unexplained neuropathy, encourage a neurological evaluation.

Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes. People volunteer to take part in clinical trials to test medical interventions including drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioural treatments and preventive care.